Sántha et al. [18] studied the expression of CD44, CD133, and ALDH1 in pancreatic cancer cells as part of a morphological subtyping scheme and found significant differences in marker expression between proposed subtypes that correlated with other morphological and immunohistochemical features. This evidence concerns the gene ALDH1A1 and familial pancreatic carcinoma.